Advertisement

Topics

Cara Therapeutics, Inc. Company Profile

00:57 EST 14th February 2016 | BioPortfolio


News Articles [43 Associated News Articles listed on BioPortfolio]

Cara Therapeutics' (CARA) CEO Derek Chalmers on Q2 2015 Results - Earnings Call Transcript

Cara Therapeutics' (CARA) CEO Derek Chalmers on Q3 2015 Results - Earnings Call Transcript

Maruishi pays $2.5 million to Cara’s pruritus drug

Biospectrum Cara is a biotechnology company focused on developing and commercializing new chemical entities designed to...

FOPO nets $65.8mm for Cara Therapeutics

Cara Therapeutics Inc. (pain and dermatological conditions) netted $65.8mm in a follow-on public offering of 3.8mm shares for $18.60. The company will spend the money on clinical trials of the IV and ...

FOPO nets $75.7mm for Cara Therapeutics

Cara Therapeutics Inc. (pain and dermatological conditions) netted $75.7mm in a follow-on public offering of 4.3mm shares (including the overallotment) for $18.60. The company will spend the money on ...

Cara Therapeutics begins CR845’s Phase II trial for osteoarthritis

Biotechnology firm Cara Therapeutics has enrolled first patients in a Phase II trial of an oral tablet formulation of its peripherally selective kappa opioid agonist CR845 to treat osteoarthritis (OA)...

UPDATE 1-Cara Therapeutics' arthritis drug meets main goal in study

Dec 9 (Reuters) - Cara Therapeutics Inc said its arthritis drug met the main goal of reducing pain in patients in the first mid-stage study.

Cara Therapeutics' arthritis drug meets main goal in study

(Reuters) - Cara Therapeutics Inc said its arthritis drug met the main goal of reducing pain in patients in the first mid-stage study.

PubMed Articles [0 Results]

None

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Protecting the 'Hood Against Tobacco

Among all racial/ethnic groups, African Americans have the greatest risk of becoming ill or dying from tobacco-related diseases. Because of this disproportionate disease burden, it is part...

Companies [4 Associated Companies listed on BioPortfolio]

CARA Therapeutics

Cara possesses both near-term clinical development opportunities, combined with proprietary approaches to developing first-in-class novel therapeutics. Cara's first patented compound, CR665, has enter...

Cara Therapeutics, Inc.

CARA THERAPEUTICS -- OU NAME

Instituto de Cirugía Maxilofacial e Implantología

Me es grato darles la bienvenida a la página web del INSTITUTO DE CIRUGIA MAXILOFACIAL E IMPLANTOLOGIA.El Instituto, fundado en Mayo del 2000, tiene como objetivo el tratamiento integral médico-quir...

More Information about "Cara Therapeutics, Inc." on BioPortfolio

We have published hundreds of Cara Therapeutics, Inc. news stories on BioPortfolio along with dozens of Cara Therapeutics, Inc. Clinical Trials and PubMed Articles about Cara Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cara Therapeutics, Inc. Companies in our database. You can also find out about relevant Cara Therapeutics, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record